Australia's most trusted
source of pharma news
Posted 20 July 2026 AM
After 23 years at Johnson & Johnson, Susan Martin has a new role, at a new company and a new mission - tasked with expanding access to genomic technologies as precision medicine broadens its footprint across Australian healthcare.
Martin, who spent seven years as Managing Director at J&J MedTech, is the new ANZ Country Leader for DNA sequencing giant, Illumina and will lead the company's commercial growth, strategic partnerships, market expansion and customer success across the research, clinical, and public health sectors.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.